NCT05050123

Brief Summary

The purpose of this study is to compare a smartphone-based virtual reality exposure with standard relaxation training for anxiety and associated symptoms (including pain) on an inpatient psychiatric unit, and whether patients find it usable and beneficial.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

October 5, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 17, 2021

Completed
Last Updated

August 14, 2023

Status Verified

August 1, 2023

Enrollment Period

2 months

First QC Date

September 10, 2021

Last Update Submit

August 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in anxiety

    Assessment of anxiety with Subjective Units of Distress Scale (SUDS); this 0-100 scale has anchors and guidance for patients to rate their anxiety, 100 is "highest anxiety/distress you have ever felt", 50 is "moderate anxiety/distress; uncomfortable, but can continue to function", and 0 is "no stress; totally relaxed".

    Baseline, approximately 90 minutes

Secondary Outcomes (5)

  • Change in associated emotions rating

    Baseline, approximately 90 minutes

  • Change in pain

    Baseline, approximately 90 minutes

  • Change in blood pressure

    Baseline, approximately 90 minutes

  • Change in heart rate

    Baseline, approximately 90 minutes

  • Change in respiratory rate

    Baseline, approximately 90 minutes

Study Arms (2)

First episode of anxiety: standard relaxation training

ACTIVE COMPARATOR

During a subject's first episode of anxiety the subject will be offered a session of standard relaxation training.

Behavioral: Standard relaxation training

Second episode of anxiety: virtual reality relaxation

EXPERIMENTAL

During a subject's second episode of anxiety the subject will be offered a session of virtual reality exposure available through the iPhone Google Cardboard virtual reality meditation/relaxation app.

Behavioral: iPhone Google Cardboard virtual reality meditation/relaxation app

Interventions

Virtual reality meditation/relaxation app that has 6 scenes of 360° visual imagery with soothing music. The patient can spend about 15 minutes exploring the app.

Second episode of anxiety: virtual reality relaxation

15 minute sessions of guided imagery using Mayo Clinic Patient Education CD-ROM "Relaxation for Your Mind and Body"

First episode of anxiety: standard relaxation training

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \- Hospitalized on inpatient Mayo Clinic Mood Disorders psychiatric unit (Generose 3W).

You may not qualify if:

  • Inability to understand English.
  • Patients with primary substance use disorders, primary psychotic disorders, major neurocognitive disorders and active self-harm behaviors and seizure disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Simon Kung, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 10, 2021

First Posted

September 20, 2021

Study Start

October 5, 2021

Primary Completion

December 17, 2021

Study Completion

December 17, 2021

Last Updated

August 14, 2023

Record last verified: 2023-08

Locations